Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses

Journal: Science Translational Medicine

Published: 2020-02-12

DOI: 10.1126/scitranslmed.aax6337

Affiliations: 21

Authors: 43

Go to article
Institutions Share
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA) 0.24
NIH National Center for Advancing Translational Sciences (NCATS), United States of America (USA) 0.23
NIH NCI Pediatric Oncology Branch, United States of America (USA) 0.16
Center for Cancer Research, Tuskegee University, United States of America (USA) 0.09
Department of Biology, Tuskegee University, United States of America (USA) 0.09
Basic Science Program (BSP), FNLCR, United States of America (USA) 0.02
MuriGenics Inc., United States of America (USA) 0.02
Seoul National University Hospital (SNUH), South Korea 0.02
NIH National Eye Institute (NEI), United States of America (USA) 0.02
NIH NCI Center for Cancer Research (CCR), United States of America (USA) 0.02
NIH NCI Center for Molecular Microscopy (CMM), United States of America (USA) 0.01
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA) 0.01
Department of Pharmacology and Molecular Sciences, JHU, United States of America (USA) 0.01
James Buchanan Brady Urological Institute, JHU, United States of America (USA) 0.01
Bloomberg-Kimmel Institute for Cancer Immunotherapy, JHU, United States of America (USA) 0.01
Department of Surgery, UW-Madison, United States of America (USA) 0.01
College of Agriculture, Environment and Nutrition Sciences (CAENS), Tuskegee University, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER